Dendrimers for sustained release of compounds
Abstract:
Dendrimer-based compositions and methods are provided, that are useful for administering pharmaceutical compositions to target cells and tissues for treatment of ocular diseases including macular degeneration, diabetic retinopathy, and retinitis pigmentosa.
Public/Granted literature
Information query
Patent Agency Ranking
0/0